abbvie

Page 2 of 3

FDA drug approvals Roche Celgene AbbVie
Newsletters

The FDA Went on an Epic Drug Approval Binge This Week: Brainstorm Health

By
August 16, 2019
Humira AbbVie patents innovtation
Health

The Dark Side of the World’s Bestselling Drug: Brainstorm Health

By
July 18, 2019
Protect at all costs: How the maker of the world’s bestselling drug keeps prices sky-high
Magazine

Protect at all costs: How the maker of the world’s bestselling drug keeps prices sky-high

By
July 18, 2019
AbbVie Allergan deal implications
Health

What the $63 Billion AbbVie Allergan Deal Says About the Drug Industry: Brainstorm Health

By
June 25, 2019
AbbVie Allergan deal
Health

What AbbVie’s $63 Billion Deal to Buy Allergan Says About the Drug Industry

By
June 25, 2019
Pharmaceutical Executives Testify At Senate Finance Committee Hearing On Drug Prices

Senator Calls Tying Drugmaker CEO Pay to High Drug Price ‘Problematic’

By
February 27, 2019
Hepatitis C drug can cure, if patients can get it
Health

Hepatitis C Drugs Can Cost $84,000. This New One May Be Just As Good—But Cost $300

By
April 12, 2018
BioGen Alzheimers
Health

Could a New Immunotherapy Medical Approach Break the Alzheimer’s Drug Curse?

By
October 24, 2017
Hepatitis C drug can cure, if patients can get it
Health

The FDA Just Approved the First Drug That Can Treat All Hepatitis C Strains in Just 8 Weeks

By
August 3, 2017
CA: Companies In California
Health

The World’s Best-Selling Drug Just Lost a Key Patent Battle

By
May 18, 2017
The Davos World Economic Forum 2015
Health

Novartis Just Got Some Great News in Its Battle for Amgen’s Market Share

By
August 31, 2016
George Scangos, CEO of Biogen Inc. speaks during Reuters Health Summit in New York
Health

Biogen Shares Are Spiking On Rumors of a Mega-Deal With Its Rivals

By
August 2, 2016
Close up of surgical tools and money
Health

Two of the World’s Best-Selling Drugs Are Headed for a Lot More Competition

By
July 15, 2016
Drugs From European Pharmaceuticals Companies As Stocks Outperformed The Stoxx 600 Index By 1.2 percentage Points
Finance

Biotech Stocks Are Down 25% So Far This Year

By
May 6, 2016
A screen displays the share price for pharmaceutical maker AbbVie on the floor of the New York Stock Exchange
Health

Samsung’s Drug Group Is Taking AbbVie to Court in Biotech Copycat Push

By
April 4, 2016

Most Popular